Emergent BioSolutions to Present at Jefferies 2012 Global Healthcare Conference

ROCKVILLE, Md.--(BUSINESS WIRE)--May. 22, 2012-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2012 Global Healthcare Conference in New York on Tuesday, June 5, 2012 at 10:30 AM Eastern. During the presentation, a member of the company's management team will provide a corporate overview, which may include a discussion of the company's recent business developments.

A webcast of this presentation will be available both live and by replay, accessible from the Emergent website http://www.emergentbiosolutions.com under "Investors".

About Emergent BioSolutions Inc.

Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at http://www.emergentbiosolutions.com.

Source: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com

 

Published Date : May 22, 2012